Author:
Sondel Paul M.,Hank Jacquelyn A.
Reference63 articles.
1. Systemic interleukin-2 modulates the anti-idiotypic response to chimeric anti-GD2 antibody in patients with melanoma;Albertini;J Immunother,1996
2. Phase IB trial of chimeric anti-GD2 antibody plus interleukin-2 for melanoma patients;Albertini;Clin Cancer Res,1997
3. Antibody-cytokine fusion protein (hu14.18-IL-2) retains biologic activity in human serum following in vivo administration for treatment of melanoma;Albertini;Proc ASCO,1999
4. T cell mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy;Becker;J Exp Med,1996
5. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma;Bendandi;Nat Med,1999
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献